In an era of rapid scientific advancement, gene therapy has emerged as a groundbreaking
approach with the potential to revolutionize the treatment of a myriad of diseases and …

Challenges in the development of treatments for hereditary hearing loss include the
exploration of the underlying pathological mechanisms, the comprehensive evaluation of …

Casgevy, the world's first approved CRISPR-based cell therapy, has been priced at $2.2
million per patient. Although this hefty price tag was widely anticipated, the extremely high …

Adoptive cell therapy with chimeric antigen receptor (CAR) has revolutionized cancer
treatment in the past decade. Now several adoptive cell therapies are approved, and …

Challenges related to the implementation of gene therapy products are daunting for low-to
middle-income countries, such as Brazil, and include the creation of an appropriate …

India, the most populous nation in the world, also has a high frequency of the sickle
hemoglobin (HbS) allele globally. The Arab Indian HbS haplotype in India is characterized …

Despite progress in healthcare services for individuals living with sickle cell disease (SCD)
in Africa, substantial gaps remain in advanced treatments for SCD. To help address this …

Background Chimeric antigen receptor T (CAR-T) cells have significantly advanced the
treatment of cancers such as leukemia and lymphoma. Traditionally, T cells are collected …

Casgevy, the world's first approved CRISPR-based cell therapy, has been priced at $2.2
million per patient. Although this hefty price tag was widely anticipated, the extremely high …

The integration of genetic engineering into pharmacological research is transforming the
landscape of precision medicine, offering the potential to revolutionize healthcare. Precision …